AJP - Renal Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 262: F932-F938, 1992;
0363-6127/92 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Siragy, H. M.
Right arrow Articles by Carey, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Siragy, H. M.
Right arrow Articles by Carey, R. M.

AJP - Renal Physiology, Vol 262, Issue 6 932-F938, Copyright © 1992 by American Physiological Society


ARTICLES

Intrarenal DA2 dopamine receptor stimulation in the conscious dog

H. M. Siragy, R. A. Felder, M. J. Peach and R. M. Carey
Department of Medicine, University of Virginia, School of Medicine, Charlottesville 22908.

DA2 dopamine receptors are present in renal blood vessels and glomeruli. Stimulation of DA1 dopamine receptors leads to renal vasodilation, diuresis, and natriuresis, but a functional role for renal DA2 receptors is largely unknown. We investigated the possible role of DA2 receptors in the control of renal function by intrarenal infusion of a highly specific DA2 agonist, LY 171555 (LY), in conscious uninephrectomized dogs (n = 5) in metabolic balance at sodium intake of 40 meq/day. The infusion of LY at 0.5 pmol.kg-1.min-1 did not change the urinary sodium excretion or renal hemodynamic function. A significant dose-dependent antidiuresis (F = 8.1, P less than 0.0001) and antinatriuresis (F = 93.3, P less than 0.0001) and a decrease in filtration fraction (F = 2.3, P less than 0.02) occurred as the LY dose was increased from 1.0 to 10.0 pmol.kg-1.min-1. There were no changes in systemic plasma renin activity, plasma aldosterone concentration, or mean arterial pressure during intrarenal LY administration. These data suggest that intrarenal DA2 receptor stimulation with LY decreases renal sodium excretion in part by hemodynamic mechanisms. Renal dopamine may act at vascular and/or glomerular DA2 receptors to modulate renal function.


This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
T. Hussain and M. F. Lokhandwala
Renal Dopamine Receptors and Hypertension
Experimental Biology and Medicine, February 1, 2003; 228(2): 134 - 142.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. Luippold, S. Schneider, V. Vallon, H. Osswald, and B. Muhlbauer
Postglomerular vasoconstriction induced by dopamine D3 receptor activation in anesthetized rats
Am J Physiol Renal Physiol, April 1, 2000; 278(4): F570 - F575.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Hussain, R. Abdul-Wahab, D. K. Kotak, and M. F. Lokhandwala
Bromocriptine Regulates Angiotensin II Response on Sodium Pump in Proximal Tubules
Hypertension, December 1, 1998; 32(6): 1054 - 1059.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. P. O'Connell, C. J. Vaughan, A. M. Aherne, S. J. Botkin, Z.-Q. Wang, R. A. Felder, and R. M. Carey
Expression of the Dopamine D3 Receptor Protein in the Rat Kidney
Hypertension, November 1, 1998; 32(5): 886 - 895.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. A. Jose, L. D. Asico, G. M. Eisner, F. Pocchiari, C. Semeraro, and R. A. Felder
Effects of costimulation of dopamine D1- and D2-like receptors on renal function
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1998; 275(4): R986 - R994.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Luippold and B. Mühlbauer
Dopamine D2 Receptors Mediate Glomerular Hyperfiltration Due To Amino Acids
J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1248 - 1252.
[Abstract] [Full Text]


Home page
HypertensionHome page
R. Ozono, D. P. O'Connell, C. Vaughan, S. J. Botkin, S. F. Walk, R. A. Felder, and R. M. Carey
Expression of the Subtype 1A Dopamine Receptor in the Rat Heart
Hypertension, March 1, 1996; 27(3): 693 - 703.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online